Table 3.
Adjusted measures of association of the Cox models for 5 and 10-year breast cancer survival rates, according to type of health care service.
| Private | ||||||
|---|---|---|---|---|---|---|
| 5 years |
10 years |
|||||
| Variables | HR * | IC 95% | p | HR * | IC 95% | p |
| Staging | ||||||
| Initial (I) | 1 | 1 | ||||
| Intermediate (II) | 1.40 | 0.39–5.04 | 0.6 | 1.31 | 0.52–3.30 | 0.6 |
| Advanced (III e IV) | 11.4 | 3.75–34.9 | <0.001 | 7.87 | 3.40–18.2 | <0.001 |
| Skin color | ||||||
| White | 1 | 1 | ||||
| Non-white | 2.23 | 0.88–5.67 | 0.09 | 2.24 | 1.01–4.96 | 0.05 |
| Chemotherapy | ||||||
| No | 1 | 1 | ||||
| Yes | 1.18 | 0.46–3.02 | 0.7 | 1.52 | 0.70–3.29 | 0.3 |
| Radiotherapy | ||||||
| No | 1 | 1 | ||||
| Yes | 0.65 | 0.24–1.74 | 0.4 | 0.75 | 0.35–1.61 | 0.5 |
| Hormone therapy | ||||||
| No | 1 | 1 | ||||
| Yes | 0.34 | 0.17–0.67 | 0.002 | 0.38 | 0.21–0.66 | 0.001 |
| Public | ||||||
| 5 years | 10 years | |||||
| Variables | HR * | IC 95% | p | HR * | IC 95% | p |
| Staging | ||||||
| Initial (I) | 1 | 1 | ||||
| Intermediate (II) | 1.98 | 0.65–5.97 | 0.2 | 1.79 | 0.75–4.25 | 0.2 |
| Advanced (III e IV) | 4.66 | 1.63–13.3 | 0.004 | 4.66 | 2.05–10.6 | <0.001 |
| Skin color | ||||||
| White | 1 | 1 | ||||
| Non-white | 1.98 | 1.19–3.28 | 0.008 | 1.91 | 1.23–2.97 | 0.004 |
| Chemotherapy | ||||||
| No | 1 | 1 | ||||
| Yes | 0.62 | 0.33–1.18 | 0.2 | 0.51 | 0.29–0.89 | 0.02 |
| Radiotherapy | ||||||
| No | 1 | 1 | ||||
| Yes | 0.47 | 0.27–0.82 | 0.008 | 0.52 | 0.31–0.88 | 0.01 |
| Hormone therapy | ||||||
| No | 1 | 1 | ||||
| Yes | 0.28 | 0.16–0.49 | <0.001 | 0.44 | 0.28–0.71 | 0.001 |
HR, hazard ratio.
CI, confidence interval.
* Also adjusted for age at diagnosis (continous).